School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Centre Médical Universitaire (CMU), Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Department of Radiology and Interventional Radiology, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland.
J Control Release. 2017 Sep 28;262:127-138. doi: 10.1016/j.jconrel.2017.07.016. Epub 2017 Jul 11.
Embolic microspheres or beads used in transarterial chemoembolization are an established treatment method for hepatocellular carcinoma patients. The occlusion of the tumor-feeding vessels by intra-arterial injection of the beads results in tumor necrosis and shrinkage. In this short review, we describe the utility of using these beads as devices for local drug delivery. We review the latest advances in the development of non-biodegradable and biodegradable drug-eluting beads for transarterial chemoembolization. Their capability to load different drugs, such as chemotherapeutics and anti-angiogenic compounds with different physicochemical properties, like charge and hydrophilicity/hydrophobicity, are discussed. We specifically address controlled and sustained drug release from the microspheres, and the resulting in vivo pharmacokinetics in the plasma vs. drug distribution in the targeted tissue.
栓塞微球或珠粒在经动脉化疗栓塞中被广泛应用于治疗肝细胞癌患者。通过向肿瘤供养血管内注射微球,可导致肿瘤坏死和缩小。在这篇简短的综述中,我们描述了将这些微球作为局部药物递送装置的用途。我们回顾了用于经动脉化疗栓塞的不可生物降解和可生物降解载药微球的最新进展。讨论了它们加载不同药物的能力,如化疗药物和抗血管生成化合物,这些药物具有不同的理化性质,如电荷和亲水性/疏水性。我们特别关注从微球中控制和持续释放药物,以及在体内的药代动力学,包括血浆中药物分布和靶向组织中的药物分布。